| |
| |
|
| Insider
Information: |
Kolterman Orville G |
| Relationship: |
SVP, Chief Medical Off... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Chief Medical Off... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-09-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
250 |
110,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2009-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,550 |
3,455 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP Research & Development |
• – – |
2010-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,360 |
4,815 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,630 |
6,445 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
155,136 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
171,457 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,529 |
7,974 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
184,277 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-11-03 |
4 |
OE |
$0.31 |
$626 |
D/D |
2,000 |
112,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical Affairs |
• – – |
2004-12-01 |
4 |
OE |
$0.31 |
$939 |
D/D |
3,000 |
97,410 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical Affairs |
• – – |
2005-01-03 |
4 |
OE |
$0.31 |
$939 |
D/D |
3,000 |
97,410 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
• – – |
2005-12-20 |
4 |
OE |
$0.31 |
$939 |
D/D |
3,000 |
113,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior Vice President |
• – – |
2003-08-01 |
4 |
OE |
$4.50 |
$1,350 |
D/D |
300 |
61,226 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-05-01 |
4 |
OE |
$0.31 |
$1,565 |
D/D |
5,000 |
124,530 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-06-01 |
4 |
OE |
$0.31 |
$1,565 |
D/D |
5,000 |
124,530 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-07-02 |
4 |
OE |
$0.31 |
$1,980 |
D/D |
5,000 |
119,690 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-10-03 |
4 |
OE |
$0.31 |
$2,191 |
D/D |
7,000 |
112,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
• – – |
2005-12-01 |
4 |
OE |
$0.31 |
$2,191 |
D/D |
7,000 |
117,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
• – – |
2006-02-01 |
4 |
OE |
$0.31 |
$3,130 |
D/D |
10,000 |
120,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2006-03-01 |
4 |
OE |
$0.31 |
$3,130 |
D/D |
10,000 |
120,941 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2006-04-03 |
4 |
OE |
$0.31 |
$3,130 |
D/D |
10,000 |
120,941 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2006-05-01 |
4 |
OE |
$0.31 |
$3,130 |
D/D |
10,000 |
120,941 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-01-16 |
4 |
OE |
$0.78 |
$3,905 |
D/D |
5,000 |
123,450 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-04-16 |
4 |
OE |
$0.31 |
$4,437 |
D/D |
6,700 |
121,230 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-02-15 |
4 |
OE |
$0.78 |
$5,233 |
D/D |
6,700 |
120,566 |
0 |
- |
|
141 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
